View live MIRA Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, MIRA financials and market news.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Baltimore, MD.
NEXT Stock Price and Chart — NASDAQ:NEXT — TradingView
Page 2 Percent of Stocks Above 200-Day Average Trade Ideas — INDEX
MRTX Stock Price and Chart — NASDAQ:MRTX — TradingView
FIA1S Stock Price and Chart — OMXHEX:FIA1S — TradingView
VMAR Stock Price and Chart — NASDAQ:VMAR — TradingView
MIRM Stock Price and Chart — NASDAQ:MIRM — TradingView
MAR Stock Price and Chart — NASDAQ:MAR — TradingView
NDRA Stock Price and Chart — NASDAQ:NDRA — TradingView
Mirati Therapeutics, Inc. Trade Ideas — NASDAQ:MRTX — TradingView
TradingView — Track All Markets
MS Stock Price and Chart — NYSE:MS — TradingView